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brachytherapy across a range of clinical applications.
 
Figure 1: Measurement vs plan for 2 dwells in each of 5 
catheters from a patient treatment fraction. A subset of all 
measurements is shown. 
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Purpose/Objective: In high dose rate (HDR) brachytherapy of 
the prostate, radioactive dwell positions are delivered by a 
single source inserted via needle catheters into the target 
volume. The rectal mucosa also recieves dose during the 
treatment, which may lead to toxicity effects. An in house 
Matlab programme was utilised to parameterise the rectal 
dose allowing for association with patient reported late 
toxicity. 
Materials and Methods: During treatment of a series of 76 
patients, using ultrasound imaging to localise the anatomy 
and catheter locations. The target volumes and OAR were 
contoured on the ultrasound scan.The anterior rectal mucosal 
wall weas identified by contouring the transrectal ultrasound 
balloon. Source positions and dwell times, along with the 
dose delivered to the patient were computed using the 
Oncentra Prostate treatment planning system (TPS). Data for 
the series of patients were exported from the TPS in DICOM 
format, and a series of parameterisation methods were 
developed in a Matlab environment to assess the rectal dose, 
as shown in figure 1. 
The change in mean LENT SOMA bowel score was calculated 
for each patient for several post-treatment time points over 
a 5 year period, using pre-treatment score as baseline. 
Association between change in mean score and radiation dose 
to the rectum was the examined using spider plots. 
 
Results: Contours of the anterior rectal mucosa were 
voxelised witthin Matlab to allow the dose to the rectal 
mucosa to be analysed directly from the 3D dose grid. Dose 
parameterisations based on dose-surface(DSH) and dose line 
(DLH) histograms were obtained. Parameters for both lateral 
and longitudinal extents of the mucosal dose were produced 
using dose-line histograms in the relevant directions. The 
results of the spider plots indicated 3 patients with the 
largest increases in mean LENT SOMA score (1.7, 1.7, 1.4) 
compared to pre treatment, had recieved higher doses of 
radiation to the rectum (50th percentile dose volumes 438, 
455, 519cGy respectively) than the majority of the patient 
sample. For these 3 the most severe side-effects were seen 
at 6 months. 
Doses ranged from 250 to 588cGy for the remaining 69 
patients. For these patients increases in mean LENT SOMA 
score were 1 or less even though a number of them had 
recieved similar radiation doses to the rectum as the 3 
patients described above. 
Conclusions: We have using Matlab found a number of 
parameters to aid in quantifying the dose to the rectal 
mucosa during HDR proate brachytherapy. the geometry of 
the transrectal probe standardises the rectal anatomy, 
making this treatment technique particularly suited to 
studies of this nature. The results of the analysis showed 
some small associations between dose and late reported 
toxicities; this is to be further studied using prospective data 
and considering other OAR. 
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Purpose/Objective: The objective is the development of a 
fully automatic inverse dose planning optimization tool for 
MRI guided focal HDR prostate brachytherapy with divergent 
needles. The optimizer is tested in a planning study by 
assessing the dose volume parameters. 
Materials and Methods: To develop a fully automatic 
optimizer for a given number of divergent needles (Figure 
1a), the following parameters need to be optimized: (1) the 
position of the center of rotation (2) the angles of the needle 
and (3) the dwell times of the sources. The idea of our 
optimization workflow is to get the most benefit of the linear 
properties of the dwell times regarding the dose. The center 
